Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Beginning Cash Balance Beginning Cash Balance Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Xtant Medical Holdings (XTNT) Cash from Operations (2016 - 2025)

Xtant Medical Holdings has reported Cash from Operations over the past 16 years, most recently at 4612000.0 for Q3 2025.

Quarterly Cash from Operations rose 368.45% to 4612000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was 7831000.0 through Sep 2025, up 158.11% year-over-year, with the annual reading at 11896000.0 for FY2024, 25.02% down from the prior year.
Cash from Operations was 4612000.0 for Q3 2025 at Xtant Medical Holdings, up from 1276000.0 in the prior quarter.
Over five years, Cash from Operations peaked at 4612000.0 in Q3 2025 and troughed at 5755000.0 in Q1 2024.
The 5-year median for Cash from Operations is 1004000.0 (2022), against an average of 1007736.84.
Year-over-year, Cash from Operations surged 955.87% in 2021 and then tumbled 16906.67% in 2023.
A 5-year view of Cash from Operations shows it stood at 423000.0 in 2021, then tumbled by 640.9% to 2288000.0 in 2022, then soared by 60.01% to 915000.0 in 2023, then surged by 172.68% to 665000.0 in 2024, then surged by 593.53% to 4612000.0 in 2025.
Per Business Quant, the three most recent readings for XTNT's Cash from Operations are 4612000.0 (Q3 2025), 1276000.0 (Q2 2025), and 1278000.0 (Q1 2025).